Midazolam
- Generic Name
- Midazolam
- Brand Names
- Buccolam, Busulfex, Nayzilam, Seizalam
- Drug Type
- Small Molecule
- Chemical Formula
- C18H13ClFN3
- CAS Number
- 59467-70-8
- Unique Ingredient Identifier
- R60L0SM5BC
- Background
Midazolam is a short-acting hypnotic-sedative drug with anxiolytic, muscle relaxant, anticonvulsant, sedative, hypnotic, and amnesic properties. It belongs to a class of drugs called benzodiazepines. This drug is unique from others in this class due to its rapid onset of effects and short duration of action. Midazolam is available by oral, rectal, intranasal...
- Indication
Midazolam has different indications depending on its formulation by the FDA.
Nasal
...
- Associated Conditions
- Epileptic seizure, Status Epilepticus
- Associated Therapies
- Anaesthesia, Anxiolytic therapy therapy, Sedation for mechanically-ventilated patients, Preoperative amnesia therapy, Preoperative sedation therapy
Evaluation of the Analgesic Effect of Midazolam and Ketamine as an Additive to Intrathecal Bupivacaine in Patients Undergoing Cesarean Section
- Conditions
- Interventions
- First Posted Date
- 2011-07-28
- Last Posted Date
- 2012-05-17
- Lead Sponsor
- Qazvin University Of Medical Sciences
- Target Recruit Count
- 90
- Registration Number
- NCT01404442
- Locations
- 🇮🇷
Qazvin university of medical science, Qazvin, Iran, Islamic Republic of
Evaluation of Pediatric Procedural Sedation With Rectal Chloral Hydrate or Intranasal Midazolam
- Conditions
- Interventions
- First Posted Date
- 2011-07-26
- Last Posted Date
- 2013-06-20
- Lead Sponsor
- University of Sao Paulo
- Registration Number
- NCT01402596
- Locations
- 🇧🇷
University of Sao Paulo, Sao Paulo, SP, Brazil
A Study to Assess the Effect Tasimelteon on the Cytochrome P450 3A4 and 2C8 Enzymes in Healthy Subjects
- Conditions
- Interventions
- First Posted Date
- 2011-07-26
- Last Posted Date
- 2014-02-17
- Lead Sponsor
- Vanda Pharmaceuticals
- Target Recruit Count
- 24
- Registration Number
- NCT01402076
- Locations
- 🇺🇸
Bio-Kinetic Clinical Applications, Springfield, Missouri, United States
Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients
- Conditions
- First Posted Date
- 2011-07-26
- Last Posted Date
- 2016-02-02
- Lead Sponsor
- Markus Joerger
- Target Recruit Count
- 54
- Registration Number
- NCT01402089
- Locations
- 🇨🇭
Cantonal Hospital St.Gallen, St.Gallen, Switzerland
A Study of LY2228820 in Participants With Advanced Cancer
- First Posted Date
- 2011-07-14
- Last Posted Date
- 2020-03-24
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 89
- Registration Number
- NCT01393990
- Locations
- 🇺🇸
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., San Antonio, Texas, United States
Nasogastric Tube Insertion Using Midazolam in the Emergency Department
- First Posted Date
- 2011-06-17
- Last Posted Date
- 2013-07-22
- Lead Sponsor
- University of Vermont
- Target Recruit Count
- 49
- Registration Number
- NCT01375634
- Locations
- 🇺🇸
Fletcher Allen Health Care Emergency Department, Burlington, Vermont, United States
Intravenous Ketamine in the Treatment of Obsessive-Compulsive Disorder
- First Posted Date
- 2011-06-10
- Last Posted Date
- 2018-01-18
- Lead Sponsor
- Wayne Goodman MD
- Target Recruit Count
- 3
- Registration Number
- NCT01371110
- Locations
- 🇺🇸
Clinical Research Centers at Icahn School of Medicine at Mount Sinai, New York, New York, United States
Trial Comparing Sedation for Endoscopy With Propofol Versus Midazolam in Cirrhotics
- First Posted Date
- 2011-05-19
- Last Posted Date
- 2011-05-19
- Lead Sponsor
- Govind Ballabh Pant Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT01356121
- Locations
- 🇮🇳
Prof Barjesh Chander Sharma, New Delhi, Delhi, India
Cycling of Sedative Infusions in Critically Ill Pediatric Patients
- Conditions
- Interventions
- First Posted Date
- 2011-04-11
- Last Posted Date
- 2019-01-15
- Lead Sponsor
- Javier Gelvez, MD
- Target Recruit Count
- 25
- Registration Number
- NCT01333059
- Locations
- 🇺🇸
Cook Children's Medical Center, Fort Worth, Texas, United States
Ultrasound-guided Axillary Plexus Block - Dose Reduction of Prilocaine
- First Posted Date
- 2011-03-07
- Last Posted Date
- 2011-07-12
- Lead Sponsor
- Helios Research Center
- Target Recruit Count
- 120
- Registration Number
- NCT01309360
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.